Medherant: Funding, Investors & Team (Sep 2026)
Professor David Haddleton and the University of Warwick established Medherant with the aim of creating fresh technology for transdermal drug delivery and bringing it to the market. Existing patch technologies have drawbacks such as low drug loading capacity, making them unsuitable for numerous pharmaceutical products that could benefit from transdermal delivery. Conversely, creams and gels have a critical deficit in terms of dose control that many drugs require.
Medherant has raised $3.6M across 1 funding round on record, the most recent an undisclosed round of $3.6M announced in Apr 2023.
That round is below the $4.7M median round size for Administrative Services companies tracked on FundedIQ over the last two years.
Medherant Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Medherant Funding Rounds
Medherant Founders and Leadership Team
No contact details are on record for this team yet.
Medherant Funding Compared to Other Administrative Services Startups
Medherant's latest round of $3.6M is below the median round in Administrative Services. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Medherant in Administrative Services and Coventry
Companies Similar to Medherant
Vaso by Eco Manufacturing will create the panel for a four-bedroom house that will be built in four days.
Ello Group provides solutions for marketing engagement, employee benefits, and data and insight services.…
Zeroramp is a European HRtech and corporate software company that creates privacy-focused AI technologies,…
The Logistics Partnership specialized in management recruitment within the logistics and supply chain sectors.
Aveni is a prestigious tech company known for its expertise in Natural Language Processing for Financial…
Pyrexia Ltd offers an AI-native cloud platform that automates recruitment, onboarding, and compliance…
Connecting Excellence Group PLC (XCE) is a international executive recruitment firm that has integrated…
We want to build a better hiring future for everyone: the people finding jobs and the businesses hiring them.…
PPHA delivers affordable homes via rental and shared ownership, supporting access to housing and stronger…
EdSync provides education technology platforms that support school operations, learning, and data management.…
Serve First offers surveys for customers to provide feedback and platforms for staff to engage with.
Cornwall-based company, Cornish Tin Limited, is making progress in transforming the Great Wheal Vor Project.…
Medherant Funding FAQs
What does Medherant do?
Professor David Haddleton and the University of Warwick established Medherant with the aim of creating fresh technology for transdermal drug delivery and bringing it to the market. Existing patch technologies have drawbacks such as low drug loading capacity, making them unsuitable for numerous pharmaceutical products that could benefit from transdermal delivery. Conversely, creams and gels have a critical deficit in terms of dose control that many drugs require.
How much funding has Medherant raised?
Medherant has raised $3.6M across 1 round on record. The most recent is an undisclosed round of $3.6M announced in Apr 2023.
When did Medherant last raise funding?
Medherant's most recent funding round on record is an undisclosed round of $3.6M, announced in Apr 2023.
Who is the CEO of Medherant?
John Burt is listed as CEO at Medherant.
Where is Medherant headquartered?
Medherant is based in Coventry, United Kingdom.
How many employees does Medherant have?
Medherant is in the 11-50 employee band.
How does Medherant's funding compare to other Administrative Services startups?
Medherant's latest round of $3.6M is below the $4.7M median round size for Administrative Services companies on FundedIQ across 1,897 tracked companies over the last two years.
About FundedIQ's Medherant Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medherant is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.